Trials / Conditions / Refractory Lung Non-Small Cell Carcinoma

Refractory Lung Non-Small Cell Carcinoma

6 registered clinical trials studyying Refractory Lung Non-Small Cell Carcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic St NCT06943664	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small C NCT05334329	University of California, Irvine	Phase 1
Active Not Recruiting	Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth F NCT04285671	Jonsson Comprehensive Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors NCT04007744	Mayo Clinic	Phase 1
Terminated	Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC NCT04081688	Rutgers, The State University of New Jersey	Phase 1
Active Not Recruiting	Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lun NCT03600701	National Cancer Institute (NCI)	Phase 2